More specifically, VEGF levels were retrospectively assessed in 679 breast cancer patients, and it was shown that VEGF levels in the triple-negative molecular subtype (n = 87) were significantly increased compared to patients with other molecular subtypes (p < 0.0001) [31]. The gene discussed is VEGFA; the disease is breast cancer.